ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 75 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,000 | -66.7% | 34,151 | -59.5% | 0.00% | – |
Q1 2022 | $60,000 | -74.9% | 84,280 | -53.5% | 0.00% | – |
Q4 2021 | $239,000 | -32.3% | 181,396 | +18.1% | 0.00% | -100.0% |
Q3 2021 | $353,000 | -58.9% | 153,544 | -21.5% | 0.00% | -50.0% |
Q2 2021 | $858,000 | +3.7% | 195,545 | +71.7% | 0.00% | 0.0% |
Q1 2021 | $827,000 | +347.0% | 113,885 | +165.8% | 0.00% | – |
Q4 2020 | $185,000 | +25.9% | 42,851 | +19.9% | 0.00% | – |
Q3 2020 | $147,000 | -36.1% | 35,746 | -6.6% | 0.00% | -100.0% |
Q2 2020 | $230,000 | -23.1% | 38,262 | -3.7% | 0.00% | 0.0% |
Q1 2020 | $299,000 | – | 39,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |